Ian Frank, M.D.
Dr. Frank is on numerous hospital and medical school committees, and national committees, such as the Undergraduate Medical Education Committee; the Institutional Review Board; the Medical Center AIDS Committee; and the Medical School HIV Curriculum Committee. He has also worked on the HIV Research Agenda Committee, Protease Inhibitor Focus Group, Adult AIDS Clinical Trials Group; and the Combination Therapy Working Group of Primary Therapy Committee, Adult AIDS Clinical Trials Group.
Dr. Frank received his M.D. from Dartmouth Medical School and is a member of many professional and scientific societies, including the American Association for the Advancement of Science, the Infectious Diseases Society of America, and the International AIDS Society.
Ian Frank, M.D., has received consulting fees from Bristol-Myers Squibb, GlaxoSmithKline, Gilead, Abbott, Pfizer and Tibotec. He has received fees for non-CME services from Bristol-Myers Squibb, GlaxoSmithKline, Gilead, Abbott, Pfizer, Tibotec and Merck. He has received fees for contracted research from Merck, Tibotec and Bavarian Nordic.